| Schedule of reconciliation of basic and diluted earnings per share |
| Schedule of reconciliation of basic and diluted earnings per share | |
| |
| |
| |
|
| | |
For the Three Months Ended | |
For the Nine Months Ended |
| | |
June 30, | |
June 30, |
| | |
2026 | |
2025 | |
2026 | |
2025 |
| Numerator: | |
| |
| |
| |
|
| Loss from continuing operations | |
$ | (68,959,000 | ) | |
$ | (2,404,000 | ) | |
$ | (937,692,000 | ) | |
$ | (5,124,000 | ) |
| Less deemed dividend on Series B Convertible Preferred Stock | |
| – | | |
| (10,000 | ) | |
| – | | |
| (10,000 | ) |
| Loss from continuing operations attributable to common shareholders | |
| (68,959,000 | ) | |
| (2,414,000 | ) | |
| (937,692,000 | ) | |
| (5,134,000 | ) |
| Income from discontinued operations, net of tax | |
| – | | |
| 1,554,000 | | |
| – | | |
| 2,114,000 | |
| Net loss attributable to common shareholders | |
$ | (68,959,000 | ) | |
$ | (860,000 | ) | |
$ | (937,692,000 | ) | |
$ | (3,020,000 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted average common shares outstanding | |
| 86,694,000 | | |
| 1,114,000 | | |
| 93,588,000 | | |
| 1,105,000 | |
| Dilutive common share equivalents | |
| – | | |
| – | | |
| – | | |
| – | |
| Weighted average dilutive shares outstanding | |
| 86,694,000 | | |
| 1,114,000 | | |
| 93,588,000 | | |
| 1,105,000 | |
| | |
| | | |
| | | |
| | | |
| | |
| Basic (loss) / earnings per share: | |
| | | |
| | | |
| | | |
| | |
| Basic loss per share from continuing operations | |
$ | (0.80 | ) | |
$ | (2.17 | ) | |
$ | (10.02 | ) | |
$ | (4.65 | ) |
| Basic earnings per share from discontinued operations | |
| – | | |
| 1.40 | | |
| – | | |
| 1.92 | |
| Basic loss per share attributable to common shareholders | |
$ | (0.80 | ) | |
$ | (0.77 | ) | |
$ | (10.02 | ) | |
$ | (2.73 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Diluted (loss) / earnings per share: | |
| | | |
| | | |
| | | |
| | |
| Diluted loss per share from continuing operations | |
$ | (0.80 | ) | |
$ | (2.17 | ) | |
$ | (10.02 | ) | |
$ | (4.65 | ) |
| Diluted earnings per share from discontinued operations | |
| – | | |
| 1.40 | | |
| – | | |
| 1.92 | |
| Diluted loss per share attributable to common shareholders | |
$ | (0.80 | ) | |
$ | (0.77 | ) | |
$ | (10.02 | ) | |
$ | (2.73 | ) |
|
| Schedule of anti-dilutive shares |
| Schedule of anti-dilutive shares | |
| |
| |
| |
|
| | |
For the Three Months Ended June 30, | |
For the Nine Months Ended June 30, |
| | |
2026 | |
2025 | |
2026 | |
2025 |
| Convertible preferred stock | |
| – | | |
| 879,000 | | |
| – | | |
| 879,000 | |
| Options and RSUs | |
| 2,763,000 | | |
| 169,000 | | |
| 2,763,000 | | |
| 169,000 | |
| Warrants | |
| 13,495,000 | | |
| 186,000 | | |
| 13,495,000 | | |
| 186,000 | |
| Total potentially dilutive shares | |
| 16,258,000 | | |
| 1,234,000 | | |
| 16,258,000 | | |
| 1,234,000 | |
|